Eciruciclib
Eciruciclib is an antineoplastic and potent cyclin dependent kinase (CDK) inhibitor[1].
Product Specifications
CAS Number
1868086-40-1
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/eciruciclib.html
Purity
98.03
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC1=C(C2=CC3=C(C(C)C)N(C)N=C3C=C2)N=C(NC4=NC=C(CN5CCN(CC5)CC)C=C4)N=C1
Molecular Formula
C27H33FN8
Molecular Weight
488.60
Precautions
H315, H319, H335
References & Citations
[1]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M1201-53J-AP 100 µL
Macrophage Derived Chemokine (MDC, CCL22) (AP) discontinued
Sign In for Pricing
View Details MBS6338227-01 0.2 mL
PSMD1, NT (PSMD1, 26S proteasome non-ATPase regulatory subunit 1, 26S proteasome regulatory subunit RPN2, 26S proteasome regulatory subunit S1, 26S proteasome subunit p112) (AP)
Sign In for Pricing
View Details MBS6338227-02 5x 0.2 mL
PSMD1, NT (PSMD1, 26S proteasome non-ATPase regulatory subunit 1, 26S proteasome regulatory subunit RPN2, 26S proteasome regulatory subunit S1, 26S proteasome subunit p112) (AP)
Sign In for Pricing
View Details 